Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice

Ir J Med Sci. 2010 Mar;179(1):99-105. doi: 10.1007/s11845-009-0389-2. Epub 2009 Jul 16.

Abstract

Introduction: The amino acid taurine has an established role in attenuating lung fibrosis secondary to bleomycin-induced injury. This study evaluates taurine's effect on TGF-beta1 expression and the development of lung fibrosis after single-dose thoracic radiotherapy.

Methods: Four groups of C57/Bl6 mice received 14 Gy thoracic radiation. Mice were treated with taurine or saline supplementation by gavage. After 10 days and 14 weeks of treatment, TGF-beta1 levels were measured in serum and bronchoalveolar lavage fluid (BALF). Lung collagen content was determined using hydroxyproline analysis.

Results: Ten days post radiotherapy, serum TGF-beta1 levels were significantly lower after gavage with taurine rather than saline (P = 0.033). BALF TGF-beta1 at 10 days was also significantly lower in mice treated with taurine (P = 0.031). Hydroxyproline content was also significantly lower at 14 weeks in mice treated with taurine (P = 0.020).

Conclusion: This study presents novel findings of taurine's role in protecting from TGF-beta1-associated development of lung fibrosis after thoracic radiation.

MeSH terms

  • Analysis of Variance
  • Animals
  • Bronchoalveolar Lavage Fluid
  • Disease Models, Animal
  • Female
  • Hydroxyproline / drug effects
  • Mice
  • Pulmonary Fibrosis / chemically induced
  • Pulmonary Fibrosis / drug therapy*
  • Pulmonary Fibrosis / etiology
  • Radiotherapy / adverse effects*
  • Taurine / pharmacology
  • Taurine / therapeutic use*
  • Thorax / radiation effects*
  • Time Factors
  • Transforming Growth Factor beta1 / blood
  • Transforming Growth Factor beta1 / drug effects*

Substances

  • Transforming Growth Factor beta1
  • Taurine
  • Hydroxyproline